Table 1. Characteristics of patients diagnosed with malignant pleural mesothelioma compensated for occupational asbestos exposure in New South Wales, 2002–2009 (n=910), by patient characteristics.
Number (value) | % | |
---|---|---|
Demographic characteristics | ||
Sex | ||
Male | 92 | 90 |
Female | 818 | 10 |
Median age at diagnosis | (72 years of age) | — |
Smoking status | ||
Never smoker | 302 | 33 |
Ex/current smoker | 464 | 51 |
Missing status | 144 | 16 |
Asbestos exposure | ||
Median age at first exposure | 18 years of age | — |
Median cumulative asbestos exposurea | 24 years | — |
Geographic location at the time of diagnosis | ||
Major city | 605 | 67 |
(Inner or outer) Regional | 302 | 33 |
Remote | 3 | <1 |
Clinical and pathological characteristics | ||
ECOG status | ||
0 | 14 | 2 |
⩾1 | 776 | 85 |
Missing | 120 | 14 |
Calretinin expression | ||
Positive expression | 681 | 75 |
Negative expression | 64 | 7 |
Testing not performed | 165 | 18 |
Clinical stage at diagnosisb | ||
Early stage disease (Stages X, I–II) | 377 | 42 |
Late stage disease (Stages III–IV) | 404 | 44 |
CT data not available | 129 | 14 |
NLR | ||
<5 | 530 | 58 |
⩾5 | 316 | 35 |
Missing | 64 | 7 |
Haemoglobin (from baseline) | ||
<1g dl−1 | 211 | 23 |
⩾1g dl−1 | 637 | 70 |
Missing | 62 | 7 |
Platelets ( × 109 l−1) | ||
<400 | 613 | 67 |
⩾400 | 232 | 26 |
Missing | 65 | 7 |
Albumin | ||
⩾35g dl−1 | 382 | 42 |
<35g dl−1 | 281 | 31 |
Missing | 247 | 27 |
White cell count | ||
<8.3 | 394 | 43 |
⩾8.3 | 453 | 50 |
Missing | 63 | 7 |
Tumour characteristics | ||
Histological subtype | ||
Epithelioid | 545 | 60 |
Biphasic | 119 | 13 |
Sarcomatoid | 153 | 17 |
Missing values | 93 | 10 |
Treatment characteristics | ||
Chemotherapy | ||
Received chemotherapy | 375 | 41 |
Received pemetrexed | 344 | 38 |
Did not receive chemotherapy | 474 | 52 |
Missing data | 61 | 7 |
Surgery | ||
Underwent EPP | 59 | 7 |
Did not undergo EPP | 851 | 93 |
Missing | 1 | 0 |
Radiotherapy | ||
Adjuvant radiotherapy performed | 37 | 4 |
Adjuvant radiotherapy not performed | 803 | 88 |
Missing | 71 | 8 |
Outcome characteristics | ||
Median overall survival | 10.0 months | — |
EORTC Prognostic Score | — | |
<3 | 305 | 34 |
⩾3 | 468 | 51 |
Missing | 137 | 15 |
Abbreviations: ECOG=Eastern Cooperative Oncology Group; EORTC=European Organisation for Research and Treatment of Cancer; EPP=extrapleural-pneumonectomy; NLR=neutrophil–lymphocyte ratio.
Estimated using data of a patients' first age at asbestos exposure and occupational history.
Categorised by clinical investigators on this study using CT scan data grouped by the AJCCC criteria.